ARK Invest Europe launches innovation, genomics and AI ETFs -- The degenerate gambler Cathie Wood knows how to milk people /sheeple

- ARK Invest Europe has launched three actively managed ETFs covering innovation, genomics, and artificial intelligence (AI) in the European market - The ETFs are listed on Deutsche Borse and will list on other exchanges in the coming weeks - Each ETF has a total expense ratio (TER) of 0.75% - The ETFs are ARK Innovation UCITS ETF (ARKK), ARK Genomic Revolution UCITS ETF (ARKG), and ARK Artificial Intelligence & Robotics UCITS ETF (ARKI) - ARKK targets disruptive innovation, while ARKG focuses on the genomic revolution, and ARKI invests in AI, autonomous technology, and robotics - ARK Invest acquired thematic specialist Rize ETF last September and will continue to operate it as a "sustainable sub-brand"